267 related articles for article (PubMed ID: 26055448)
1. Activation of AMPK restricts coxsackievirus B3 replication by inhibiting lipid accumulation.
Xie W; Wang L; Dai Q; Yu H; He X; Xiong J; Sheng H; Zhang D; Xin R; Qi Y; Hu F; Guo S; Zhang K
J Mol Cell Cardiol; 2015 Aug; 85():155-67. PubMed ID: 26055448
[TBL] [Abstract][Full Text] [Related]
2. CVB3 Nonstructural 2A Protein Modulates SREBP1a Signaling via the MEK/ERK Pathway.
Wang L; Xie W; Zhang L; Li D; Yu H; Xiong J; Peng J; Qiu J; Sheng H; He X; Zhang K
J Virol; 2018 Dec; 92(24):. PubMed ID: 30258014
[TBL] [Abstract][Full Text] [Related]
3. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
5. Baicalin Inhibits Coxsackievirus B3 Replication by Reducing Cellular Lipid Synthesis.
Wang MJ; Yang CH; Jin Y; Wan CB; Qian WH; Xing F; Li X; Liu YY
Am J Chin Med; 2020; 48(1):143-160. PubMed ID: 31903780
[TBL] [Abstract][Full Text] [Related]
6. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.
Liu H; Li M; Song Y; Xu W
Front Immunol; 2018; 9():2479. PubMed ID: 30410495
[TBL] [Abstract][Full Text] [Related]
7.
Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
[TBL] [Abstract][Full Text] [Related]
8. Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release.
Si X; Luo H; Morgan A; Zhang J; Wong J; Yuan J; Esfandiarei M; Gao G; Cheung C; McManus BM
J Virol; 2005 Nov; 79(22):13875-81. PubMed ID: 16254323
[TBL] [Abstract][Full Text] [Related]
9. Emodin inhibits coxsackievirus B3 replication via multiple signalling cascades leading to suppression of translation.
Zhang HM; Wang F; Qiu Y; Ye X; Hanson P; Shen H; Yang D
Biochem J; 2016 Feb; 473(4):473-85. PubMed ID: 26621875
[TBL] [Abstract][Full Text] [Related]
10. FUS/TLS Suppresses Enterovirus Replication and Promotes Antiviral Innate Immune Responses.
Xue YC; Ng CS; Mohamud Y; Fung G; Liu H; Bahreyni A; Zhang J; Luo H
J Virol; 2021 May; 95(12):. PubMed ID: 33827951
[TBL] [Abstract][Full Text] [Related]
11. Coxsackievirus B3 induces autophagy in HeLa cells via the AMPK/MEK/ERK and Ras/Raf/MEK/ERK signaling pathways.
Xin L; Ma X; Xiao Z; Yao H; Liu Z
Infect Genet Evol; 2015 Dec; 36():46-54. PubMed ID: 26305625
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-22-3p displaces critical host factors from the 5' UTR and inhibits the translation of Coxsackievirus B3 RNA.
Rani P; George B; V S; Biswas S; V M; Pal A; Rajmani RS; Das S
J Virol; 2024 Feb; 98(2):e0150423. PubMed ID: 38289119
[TBL] [Abstract][Full Text] [Related]
13. Effect of prophylactically applied CpG ODN on the development of myocarditis in mice infected with Coxsackievirus B3.
Zhao T; Wu X; Song D; Fang M; Guo S; Zhang P; Wang L; Wang L; Yu Y
Int Immunopharmacol; 2012 Dec; 14(4):665-73. PubMed ID: 23063973
[TBL] [Abstract][Full Text] [Related]
14. Coxsackievirus B3 engineered to contain microRNA targets for muscle-specific microRNAs displays attenuated cardiotropic virulence in mice.
He F; Yao H; Wang J; Xiao Z; Xin L; Liu Z; Ma X; Sun J; Jin Q; Liu Z
J Virol; 2015 Jan; 89(2):908-16. PubMed ID: 25339771
[TBL] [Abstract][Full Text] [Related]
15. Th17 cells contribute to viral replication in coxsackievirus B3-induced acute viral myocarditis.
Yuan J; Yu M; Lin QW; Cao AL; Yu X; Dong JH; Wang JP; Zhang JH; Wang M; Guo HP; Cheng X; Liao YH
J Immunol; 2010 Oct; 185(7):4004-10. PubMed ID: 20802148
[TBL] [Abstract][Full Text] [Related]
16. Coxsackievirus B3-induced calpain activation facilitates the progeny virus replication via a likely mechanism related with both autophagy enhancement and apoptosis inhibition in the early phase of infection: an in vitro study in H9c2 cells.
Li M; Wang X; Yu Y; Yu Y; Xie Y; Zou Y; Ge J; Peng T; Chen R
Virus Res; 2014 Jan; 179():177-86. PubMed ID: 24177271
[TBL] [Abstract][Full Text] [Related]
17. Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway.
Si X; McManus BM; Zhang J; Yuan J; Cheung C; Esfandiarei M; Suarez A; Morgan A; Luo H
J Virol; 2005 Jul; 79(13):8014-23. PubMed ID: 15956547
[TBL] [Abstract][Full Text] [Related]
18. Liver X receptor activation enhances CVB3 viral replication during myocarditis by stimulating lipogenesis.
Papageorgiou AP; Heggermont W; Rienks M; Carai P; Langouche L; Verhesen W; De Boer RA; Heymans S
Cardiovasc Res; 2015 Jul; 107(1):78-88. PubMed ID: 25998987
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication.
Qiu Y; Ye X; Zhang HM; Hanson P; Zhao G; Tong L; Xie R; Yang D
PLoS Pathog; 2017 Dec; 13(12):e1006744. PubMed ID: 29220410
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of IL-2 inducible T-cell kinase alleviates T-cell activation and murine myocardial inflammation associated with CVB3 infection.
He F; Yao H; Xiao Z; Han J; Zou J; Liu Z
Mol Immunol; 2014 May; 59(1):30-8. PubMed ID: 24462896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]